Fareon Open Label Device Clinical Trial

Starting soon · Not applicable

Conditions studied: Cognitive Dysfunction, Acquired Brain Injury, Traumatic Brain Injury

In brief

The purpose of this study is to assess the safety and feasibility of an at-home MMT treatment in patients with cognitive dysfunction related to acquired brain injury, Long COVID, traumatic brain injury, myalgic encephalomyelitis (ME/CFS), and other neurodegenerative diagnoses including but not limited to Alzheimer's disease and to collect data on safety and efficacy to inform the design of larger clinical studies.

Key facts

Study ID

NCT07600320

Run by

Icahn School of Medicine at Mount Sinai

People needed

30

Starts

2026-05-01

Expected to finish

2027-04-30

Last updated by the study team

2026-05-20

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Individual who meets any of the following criteria will be excluded from participation in this study:
• Enrollment in another interventional clinical trial in the last 90 days or during the study period
• Change in anti-depressant or other psychoactive medication or dose in the last 90 days
• Cranially implanted devices or metal
• Pacemaker
• History of seizure disorder
• Pregnant or plan to become pregnant during the study as indicated by proof of a positive pregnancy test
• Inability to achieve appropriate positioning of the study device on the head
• Any medical, psychiatric, or neurological condition, or concurrent treatment, that in the opinion of the Principal Investigator would interfere with study participation, interpretation of results, or pose additional risk to the participant.

Where it is running

• The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE) — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.